Charlotte Kvasnovsky to Aged
This is a "connection" page, showing publications Charlotte Kvasnovsky has written about Aged.
Connection Strength
0.256
-
Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study. Eur J Gastroenterol Hepatol. 2018 Jan; 30(1):107-112.
Score: 0.047
-
Elderly patients have more infectious complications following laparoscopic colorectal cancer surgery. Colorectal Dis. 2016 Jan; 18(1):94-100.
Score: 0.041
-
Diverticular disease as a chronic gastrointestinal condition: experience from a specialist clinic. Eur J Gastroenterol Hepatol. 2015 Apr; 27(4):442-8.
Score: 0.039
-
Expansion of screening mammography in the Veterans Health Administration: implications for breast cancer treatment. JAMA Surg. 2013 Nov; 148(11):999-1004.
Score: 0.036
-
The Association of Structural Inequities and Race With Out-of-Hospital Sudden Death During the COVID-19 Pandemic. Circ Arrhythm Electrophysiol. 2021 05; 14(5):e009646.
Score: 0.015
-
Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study. Hepatol Int. 2021 Jun; 15(3):766-779.
Score: 0.015
-
Usefulness of Elevated Troponin to Predict Death in Patients With COVID-19 and Myocardial Injury. Am J Cardiol. 2021 01 01; 138:100-106.
Score: 0.014
-
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study. PLoS Med. 2015 Dec; 12(12):e1001932.
Score: 0.010
-
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance. Clin Infect Dis. 2016 Feb 15; 62(4):418-430.
Score: 0.010
-
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies. Lancet Respir Med. 2015 Mar; 3(3):201-9.
Score: 0.010
-
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis. Clin Infect Dis. 2014 Oct 15; 59(8):1049-63.
Score: 0.009
-
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet. 2012 Oct 20; 380(9851):1406-17.
Score: 0.008